Stock A039200 OSCOTEC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Oscotec Inc.

Equities

A039200

KR7039200001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-12 pm EDT 		5-day change 1st Jan Change
28,500 KRW -1.55% Intraday chart for Oscotec Inc. -8.51% +23.64%
Feb. 23 Oscotec/Adel Initiates First-In-Human Dosing in Ph1 of Anti-Mtbr Tau Antibody Adel-Y01 in Alzheimer's Disease CI
2023 Oscotec Inc. and ADEL Inc. Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease CI

Business Summary

Oscotec Inc.,Ltd is a Korea-based company mainly engaged in the manufacture of functional medical materials and related products. The Company operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 54

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medical
52.9 %
2,737 54.1 % 2,617 52.9 % -4.39%
New Drug
26.0 %
- - 1,287 26.0 % -
Food
15.2 %
802 15.8 % 751 15.2 % -6.26%
Functional Materials
6.0 %
- - 295 6.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.6 %
5,060 100.0 % 4,930 99.6 % -2.58%
Overseas
0.4 %
2 0.0 % 21 0.4 % +809.19%

Managers

Managers TitleAgeSince
Tae-Young Yun CEO
 Chief Executive Officer 61 -
Jeong-Keun Kim CEO
 Chief Executive Officer 64 98-12-07
Yoon-Tae Kim CTO
 Chief Tech/Sci/R&D Officer 61 -
Sang-Hyeon Lee BRD
 Director/Board Member 51 99-08-31
Chang-Nam Kim AUD
 Comptroller/Controller/Auditor 64 09-02-28

Members of the board

Members of the board TitleAgeSince
Jeong-Keun Kim CEO
 Chief Executive Officer 64 98-12-07
Sang-Hyeon Lee BRD
 Director/Board Member 51 99-08-31
Tae-Young Yun CEO
 Chief Executive Officer 61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,993,965 33,075,965 ( 87.06 %) 0 86.60 %
Stock B 0 201,159 0 0

Shareholders

NameEquities%Valuation
Jeong-Keun Kim
12.54 %
4,763,955 12.54 % 106 M ₩
Sang-ho Lee
8.478 %
3,221,035 8.478 % 71 M ₩
Gk Asset
2.524 %
958,900 2.524 % 21 M ₩
Ki-yoon Lee
2.500 %
950,000 2.500 % 21 M ₩
Hyo-jin Lee
2.491 %
946,258 2.491 % 21 M ₩
Sang-gi Park
0.2181 %
82,854 0.2181 % 2 M ₩
Sang-Hyeon Lee
0.1525 %
57,949 0.1525 % 1 M ₩
Korea Investment Management Co., Ltd.
0.0158 %
6,005 0.0158 % 133 169 ₩
Oscotec, Inc. Employee Stock Ownership Association
0.0115 %
4,378 0.0115 % 97 088 ₩
Mirae Asset Global Investments Co., Ltd.
0.004495 %
1,708 0.004495 % 37 877 ₩

Company contact information

Oscotec, Inc.

9/F, Building A, Korea Bio Park 700 Daewangpangyo-ro

13488, Seongnam-si

+

http://www.oscotec.com
address Oscotec Inc.(A039200)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Oscotec Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28,500 KRW
Average target price
46,500 KRW
Spread / Average Target
+63.16%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
OSCOTEC INC. Stock Oscotec Inc.
+23.64% 796M
MERCK KGAA Stock Merck KGaA
+8.85% 72.5B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+13.69% 9.11B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-11.75% 5.07B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+59.61% 5.01B
YUHAN CORPORATION Stock Yuhan Corporation
+2.62% 3.85B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-17.54% 2.46B
INDIVIOR PLC Stock Indivior PLC
+21.72% 2.44B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-27.82% 2.26B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+25.13% 2.27B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A039200 Stock
  4. Company Oscotec Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW